Ashland Inc.
Financials
Valuation Metrics
Ashland Inc.'s Market Cap is $3.29B. At end of 2025 it was $2.69B. Ranked #1699 of 3,112 in US market (top 55%), #1094 of 1,667 on NYSE (top 66%), #96 of 173 in Materials (top 55%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $3.29B | US#1,699/3,112 Sec#96/173 |
| Revenue | $1.84B | US#1,534/3,112 Sec#103/173 |
| Net Income | $52M | US#1,845/3,112 Sec#107/173 |
| Total Assets | $4.58B | US#1,489/3,112 Sec#82/173 |
| Net Assets | $1.87B | US#1,299/3,112 Sec#85/173 |
| Employees | 2,900 | US#1,011/3,112 Sec#50/173 |
| Value | ||
| P/E | 63.18x | US#1,947/3,112 Sec#113/173 |
| P/B | 1.76x | US#1,027/3,112 Sec#66/173 |
| P/S | 1.78x | US#1,130/3,112 Sec#74/173 |
| EV/EBITDA | 12.07x | US#1,074/3,112 Sec#87/173 |
| FCF Yield | 9.83% | US#524/3,112 Sec#19/173 |
| Profitability | ||
| ROE | 2.78% | US#2,006/3,112 Sec#111/173 |
| ROA | 1.14% | US#1,892/3,112 Sec#111/173 |
| Op. Margin | 7.33% | US#1,861/3,112 Sec#111/173 |
| Revenue Growth | 7.34% | US#1,510/3,112 Sec#102/173 |
| Earnings Growth | -600.00% | US#2,340/3,112 Sec#133/173 |
| Financial Health | ||
| Debt Ratio | 144.81% | US#1,455/3,112 Sec#125/173 |
| Total Debt | $1.48B | US#1,287/3,112 Sec#66/173 |
| FCF | $323M | US#1,091/3,112 Sec#65/173 |
| Cash | $440M | US#1,157/3,112 Sec#71/173 |
| Current Ratio | 3.05x | US#792/3,112 Sec#51/173 |
| Net Debt/EBITDA | 2.89x | US#1,630/3,112 Sec#111/173 |
| Dividend | ||
| Div. Yield | 2.31% | US#810/3,112 Sec#35/173 |
| Div. Growth | 3.79% | US#911/3,112 Sec#56/173 |
| Performance | ||
| 1Y Return | 45.23% | US#845/3,112 Sec#67/173 |
| 1M Return | 7.07% | US#751/3,112 Sec#29/173 |
| From 52W High | -4.32% | US#489/3,112 Sec#11/173 |
| 1Y MDD | -24.17% | US#982/3,112 Sec#31/173 |
| Trading | ||
| Volume | 454,515 shares | US#2,138/3,112 Sec#114/173 |
| Trading Value | $33M | US#1,665/3,112 Sec#88/173 |
| Per Share | ||
| EPS | $-14.97 | US—/3,112 Sec—/173 |
| BPS | $40.69 | US#574/3,112 Sec#35/173 |
Company Info
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.